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Abstract 
 
 
With advances in acute medical care, longevity has increased in persons with SCI; 
however, morbidity due to cardiovascular disease (CVD) occurs at an earlier age compared to 
the general population.  Arterial stiffness (AS) is recognized as an independent risk factor for 
CVD and, specifically, pulse wave velocity (PWV) has been proven to be a valid tool to predict 
and track structural arterial changes that reflect arteriosclerosis. Evidence has shown that persons 
with SCI have increased AS compared to uninjured able-bodied controls; however, possible 
contributors to this increase are not yet fully understood. After a SCI, sympathetic control in the 
regions below the lesion level are severely disrupted; however, parasympathetic function is 
preserved. Due to the dissociation between the two systems, those with lesions above T6 
experience low resting blood pressure (BP) and further decreases in BP when changing postures 
(orthostatic hypotension (OH)). As a consequence, individuals with high-level injuries have a 
heightened reliance on the renin-angiotensin-aldosterone system (RAAS) to maintain and 
stabilize BP. A mechanism for increased AS in the uninjured population is over activation of the 
RAAS. In this study, individuals with high-level SCI (injured above T1) and low-level SCI 
(injured between T6-T12) had increased AS compared to age-matched controls. The change in  
renin from supine rest to 60-degree head-up tilt (HUT) was a significant predictor to the change 
in systolic BP; however, the group predictor was not significant. Additionally, group and change 
in renin were significant predictors to AS. The data indicate that individuals with high-level 
injuries rely heavily on RAAS to maintain and normalize BP during OH, which is correlated to 
increased AS. A better way to treat asymptomatic OH in the SCI population is needed to 
decrease CVD.  
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Chapter I 
 
INTRODUCTION 
 
 
Approximately 17,000 new spinal cord injuries (SCI) occur each year in the United States 
(National Spinal Cord Injury Statistical Center). The spinal cord is a critical component to send 
sensory information to the brain and for regulation of motor and autonomic functions (Kirshblum 
& Campagnolo, 2011, p. 6). The loss of the supraspinal control leads to reduced control of 
overall sympathetic activity below the level of lesion (LOI) and unopposed parasympathetic 
outflow through the intact vagal nerve. Disruption of the autonomic nervous system (ANS) leads 
to altered cardiovascular function including heart rate (HR), blood pressure (BP) and vasomotor 
tone (Kirshblum & Campagnolo, 2011, p. 136).  Due to segmental differences in sympathetic 
innervation, cardiovascular dysfunction is directly related to the specific level and severity of the 
SCI, including resting hypotension (low BP) and large fluctuations in BP (Kirshblum & 
Campagnolo, 2011, p. 136; Krassioukov, Warburton, Teasell, Eng, & Team, 2009; Lee, Phillips, 
& Krassioukov, 2017).  Early recognition and management of cardiovascular dysfunction is 
important in the SCI population.  
Cardiovascular disease (CVD) has emerged as the leading cause of mortality in individuals 
with SCI (Cragg, Noonan, Krassioukov, & Borisoff, 2013; Hagen, Lie, Rekand, Gilhus, & 
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Gronning, 2010). In fact, it has been speculated that premature cardiovascular aging in persons 
with SCI may be due to chronic inflammation (Wang et al., 2007), sedentary lifestyle (Stoner, 
Credeur, Dolbow, & Gater, 2015), and dysfunction in cardiovascular autonomic control (Myers, 
Lee, & Kiratli, 2007; West, Mills, & Krassioukov, 2012). Matos–Souza and colleagues (2009) 
demonstrated that individuals with SCI had higher common carotid artery (CCA) intima-media 
thickness (measure of vascular stiffness) than able-bodied controls even after controlling for 
traditional cardiovascular risk factors (Matos-Souza et al., 2009). Thus, other non-traditional risk 
factors may play a role in increased atherosclerosis (hardening of arterial walls).  
Individuals with injuries above T6 are more prone to experience orthostatic hypotension 
(OH) which is a decrease in BP within 3-minutes of moving from supine to the upright position, 
with or without symptoms (Neurology, 1996).  Evidence has suggested that there is an 
association between markedly reduced plasma norepinephrine (NE) and orthostatic hypotension 
(OH) (Claydon, Steeves, & Krassioukov, 2006; Wecht & Bauman, 2018; Wecht et al., 2008). 
Decreased NE reflects impaired sympathetically mediated vasoconstriction and inability to 
stimulate the adrenal medulla (Claydon et al., 2006). However, these individuals have reduced 
symptoms associated with pre-syncope which is believed to be due to increased dependency on 
the renin-angiotensin-aldosterone system (RAAS), which has been shown to occur independently 
of the SNS p. 142 (Kirshblum & Campagnolo, 2011; Wecht & Bauman, 2018). Individuals with 
a diminished plasma NE response to OH may demonstrate increased reliance on the RAAS for 
BP maintenance.  
 A possible link between increased RAAS and arterial stiffness (AS) may explain the 
increased incidence of CVD in the SCI population (Katzelnick et al., 2017;  Wecht & Bauman, 
2018). In the general population, inappropriate chronic activation of RAAS activates signal 
3 
 
transduction pathways that promote cell growth, inflammation and fibrosis (Duprez, 2006). 
Thus, individuals with high cord lesions may be more susceptible to increased AS; however, the 
association between RAAS and AS in the SCI population has not been established. Increased AS 
has been reported in high-level SCI (C3-T5) compared to low-level SCI (T7-T12) (Katzelnick 
2017); while other prior work has documented increased AS in low-level SCI (T1-T12) 
compared to high-level SCI (C2-C8) (Miyatani et al., 2014). Further investigation is needed to 
ascertain the relationship between lesion level and AS.  
Non-invasive testing modalities have been developed to more easily and accurately screen 
AS and track atherosclerosis (Stoner et al., 2015). Specifically, pulse wave velocity (PWV) 
measured at the carotid and femoral arteries is considered the gold standard measurement of AS 
(Stoner et al., 2015; Van Bortel et al., 2011) because of its high reliability (Currie, Hubli, & 
Krassioukov, 2014; Miyatani et al., 2012) and validity to track CVD (Van Bortel et al., 2011; 
Vlachopoulos et al., 2010). PWV is calculated by measuring the time taken for the arterial 
waveform to pass between two points (carotid and femoral) of a measured distance apart (Stoner 
et al., 2015; Van Bortel et al., 2011). 
The primary purpose of this research study will be to investigate the influence of orthostatic 
change of BP and NE on the RAAS responses to orthostasis. Our first hypothesis is there will be 
a linear relationship between the change in orthostatic BP and change in plasma NE 
concentration from supine rest to 60º HUT. Second hypothesis is plasma renin activity will be 
inversely related to plasma NE concentrations during HUT in persons with SCI. Additionally, 
our secondary aim will be to determine if increased reliance on the RAAS for orthostatic BP 
regulation contributes to differences in supine AS in individuals with SCI. Our hypotheses are 
the change of renin from supine rest to orthostatic tilt will be associated with supine PWV in 
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high-level SCI and there will be no relationship among the change of renin from the supine rest 
to orthostatic tilt with supine PWV in low-level SCI and controls. 
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Chapter II 
 
LITERATURE REVIEW 
 
 
A traumatic spinal cord injury (SCI) is a sudden devastating condition that affects a 
person’s everyday activities and it has been estimated that there are approximately 17,730 new 
cases of SCI each year in the United States (White & Black, 2016). An injury to the spine 
interrupts neural transmission from cortical centers to destinations below the level of injury 
(LOI), which may adversely impact regulation of the cardiovascular system by the autonomic 
nervous system (ANS), which may be dependent on the LOI and the degree of motor and 
sensory dysfunction (Garstang & Miller-Smith, 2007; Kirshblum & Campagnolo, 2011; West, 
Mills, & Krassioukov, 2012). Improvements in acute and sub-acute care post injury have resulted 
in increased life expectancy for individuals with SCI, contributing to increased risk of age-
associated disorders including cardiovascular disease (CVD), which is a leading cause of 
mortality and morbidity in individuals with chronic SCI (Myers, Lee & Kiratli, 2007). Arterial 
stiffness (AS) is one of the earliest detectable indicators of changes in vascular remodeling which 
may be a predictor of CVD progression (Balta et al., 2014; Cavalcante, Lima, Redheuil, & Al-
Mallah, 2011; Stéphane Laurent & Boutouyrie, 2007; Vlachopoulos, Aznaouridis, & Stefanadis, 
2010). Understanding the underpinnings of CVD in this population by measuring AS can help 
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clinicians more effectively screen and detect individuals with SCI at increased risk thereby 
preserving cardiovascular health and longevity.  
An intact spinal cord is responsible for transmitting neuronal signals from the periphery 
to the brain and back to properly regulate sensory, motor and autonomic function (Nógrádi & 
Vrbová, 2006). This multifaceted network of neurons is critically dependent on connection to the 
brain and cannot function appropriately under circumstances of partial or complete cortical 
disconnection (Nógrádi & Vrbová, 2006). The nervous system is divided into central and 
peripheral nervous systems. The central nervous system (CNS) includes the brain and spinal cord 
(Robertson, Low, & Polinsky, 2011). The peripheral nervous system is comprised of the somatic, 
enteric, and ANS, each controlling specific aspects of organ function. The somatic nervous 
system regulates voluntary movement in the skeletal muscles and responds to sensory feedback 
from afferent peripheral nerve transmission (Brodal, 2004).  The enteric nervous system controls 
function of the gastrointestinal tract (esophagus, stomach and intestines) and is thought to 
coordinate and direct the functions of the digestive system (Furness, 2006).  
The ANS has two branches, the sympathetic nervous system (SNS) and the 
parasympathetic nervous system (PNS), which regulate the cardiovascular system controlling 
hemodyanmic function including blood pressure (BP), heart rate (HR) (Kirshblum & 
Campagnolo, 2011), coronary blood flow and peripheral vasomotor tone (Garstang & Miller-
Smith, 2007; West et al., 2012) on a beat-by-beat basis. The ANS regulates these functions in 
response to afferent feedback from the periphery by altering neural efferent transmission to alter 
cardiac chronotropy (HR) and inotropy (myocardial contractility) as well as peripheral 
vasomotor tone  (Garstang & Miller-Smith, 2007). While both the SNS and PNS are actively 
involved in cardiovascular regulation, the PNS is primarily involved in modulating cardiac 
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chronotropy through direct innervation of the sinoatrial node (SA-node), whereas the SNS 
controls cardiac rate and contractility as well as vascular tone (Kirshblum & Campagnolo, 2011).  
SNS control originates in the rostroventrolateral medulla (RVLM) and modulates the 
cardiovascular system through sympathetic preganglionic neurons, which stem from the 1st 
thoracic vertebra (T1) to the 2nd lumbar vertebra (L2) (Kirshblum & Campagnolo, 2011).  Pre-
ganglionic sympathetic nerve fibers travel on to the postganglionic neurons which directly 
innervate target organs resulting in an increase in peripheral SNS activity (Phillips & 
Krassioukov, 2015). Origin of SNS innervation to the heart and the upper extremity vasculature 
is from T1-T4, whereas, SNS innervation to the blood vessels of the splanchnic bed and lower 
extremity originates at spinal segments T6-T12 (Kirshblum & Campagnolo, 2011). Control over 
the blood volume in the vascular bed regulate stroke volume and cardiac output, which controls 
arterial BP (Kirshblum & Campagnolo, 2011).Thus, the LOI may play a direct role in altering 
SNS cardiovascular regulation.   On the contrary, origin of PNS cardiovascular innervation is 
through the vagus nerve and cranial nerve X which exits the brain stem above the cervical spine.  
Therefore, SCI does not anatomically alter PNS cardiac innervation although functional 
impairment may be evident (Krassioukov et al., 2012).  
The spinal cord receives sensory information from somatic and visceral receptors through 
afferent nerves and transmits this information to supraspinal regulatory centers through 
ascending tracts. The brain structures then transmit these signals to muscle and organ targets 
sites through the efferent nerves (Campagnolo, Kirshblum, Nash, Heary, & Gorman, 2011).  SCI 
affects the somatic nervous system because the conduction of sensory and motor signals cannot 
transmit across the site of lesion appropriately (Kirshblum et al., 2011); thus, it is important to 
classify these individuals into a sensory and motor level by assessing dermatome, area of skin 
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innervated by sensory axons, and myotomes, muscle fibers innervated by the motor axons 
(Kirshblum et al., 2011). The American Spinal Injury Association (ASIA) provides a more 
precise approach to grade the degree of motor and sensory impairment (Kirshblum et al., 2011). 
Complete motor and sensory injury are classified as ASIA impairment scale (AIS) A and is 
defined as having no sensory or motor function below the neurological LOI. AIS B, C and D are 
considered incomplete injuries, which have some partial preservation of sensory (AIS B) and/or 
motor function (AIS C & D) below the lesion level  (Kirshblum et al., 2011). Physiologic 
changes are directly related to the level and completeness of motor and sensory injury with 
greater impairments in individuals with higher level and more complete lesions (Kirshblum & 
Campagnolo, 2011); however, the level of ANS impairment may not relate to AISA 
classification of motor and sensory impairment (Krassioukov et al., 2012).  
After a SCI, descending sympathetic preganglionlic neurons are disrupted causing loss of 
supraspinal regulation of cardiovascular function (Kirshblum & Campagnolo, 2011; Phillips, 
Krassioukov, Ainslie, & Warburton, 2012), resulting in a reduction or absence of autonomic 
cardiovascular control that may be directly related to the LOI and severity of trauma to the cord 
(Garstang & Miller-Smith, 2007; S. Kirshblum & Campagnolo, 2011; West et al., 2012). After a 
high-level injury (T1 and above), there is interruption of the descending signals from the medulla 
to the thoracic spinal cord thereby altering SNS, but preserving PNS cardiovascular control 
(Garstang & Miller-Smith, 2007;  Krassioukov, Warburton, Teasell, Eng, & Team, 2009; 
Partida, Mironets, Hou, & Tom, 2016; Phillips & Krassioukov, 2015; West, Alyahya, Laher, & 
Krassioukov, 2013), which results in resting hypotension, orthostatic hypotension (OH) and 
episodes of extreme high and low BP (Kirshblum & Campagnolo, 2011; Krassioukov et al., 
2009; Krassioukov, Karlsson, Wecht, & Wuermser, 2007; Phillips & Krassioukov, 2015; Wecht 
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& Bauman, 2013; West et al., 2013). Another name for individuals with high cord injuries is 
tetraplegic, which refers to an injury to the cervical spine and results in motor, sensory and ANS 
impairment of the upper and lower extremity, the truck and pelvic organs ( Kirshblum et al., 
2011). Although there is interruption between the sympatho-excitatory pathways from the 
brainstem to the sympathetic preganglionic neurons, hypotensive individuals with tetraplegia 
remain clinically asymptomatic (no symptoms of dizziness, blurred vision, light-headedness, 
etc.) (Handrakis et al., 2009; Wecht et al., 2011; Wecht, Rosado-Rivera, Handrakis, Radulovic, 
& Bauman, 2010). Support of the renin-angiotensin-aldosterone system (RAAS) is believed to be 
upregulated and adequately compensates for the lack of SNS vascular control in this population 
(Handrakis et al., 2009; Popa et al., 2010; Wecht & Bauman, 2018; Wecht et al., 2011; Wecht et 
al., 2010).  
The RAAS plays an essential role in maintaining long-term BP and has been detected in 
tissues such as heart, kidney, peripheral vasculature and the brain (Aroor et al., 2014; DeMello & 
Frohlich, 2009). In uninjured controls, when the baroreceptors sense a decrease in BP and blood 
volume, the kidneys release renin, primarily by the juxtaglomerular cells, to activate the RAAS 
(DeMello & Frohlich, 2009).  This system is an enzymatic cascade in which renin is released 
into the blood and acts on angiotensinogen to form angiotensin I, which forms angiotensin II 
(ANG II) by the angiotensin converting enzyme (ACE) (Bandeira, Gharib, Golbert, Griz, & 
Faria, 2013; DeMello & Frohlich, 2009; Gordan, Gwathmey, & Xie, 2015).  ANG II is a potent 
vasoconstrictor primarily by increasing BP and secondarily by increasing  retention of sodium 
and water and by stimulating aldosterone release from adrenal glands (DeMello & Frohlich, 
2009).  Recent evidence has suggested that ANG II not only plays a role in cardiovascular 
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physiology, but also may contribute to cardiovascular pathophysiology (Husain, Hernandez, 
Ansari, & Ferder, 2015; Mehta & Griendling, 2007; Zhong et al., 2010).  
Despite the important benefits of the RAAS in regulating BP homeostasis, there is recent 
evidence that chronic overproduction of ANG II may result in remodeling and restructuring of 
peripheral and coronary blood vessels, heart and the kidneys by augmenting the generation of 
reactive oxygen species, a main molecule responsible for inflammation (Duprez, 2006; Weir & 
Rolfe, 2010). ANG II has been shown to create oxidative stress in vessel walls, and enhance 
production of inflammation, thrombosis and fibrosis specifically on vascular smooth muscle cells 
and endothelial cells (Duprez, 2006). Additionally, ANG II is a major contributor in profibrotic 
mechanisms including increasing the production of matrix metalloproteinases, which modulate 
collagen and elastin turnover in the vascular wall (Duprez, 2006). All of these adverse effects 
may result in chronic inflammation of vessel walls, which is a major facet of atherosclerosis (El 
Bekay et al., 2003). Recent evidence has demonstrated that the use of ACE inhibitors or ANG II 
receptor blockers (ARBs) reduce vascular remodeling (Mahmud & Feely, 2000; Shahin, Khan, 
& Chetter, 2012; Yusuf et al., 2000), and moreover, the use of ARBs have been shown to 
decrease vasculature stiffness independent of BP (Karalliedde et al., 2008; Azra Mahmud & 
Feely, 2004; Shahin et al., 2012).  Using ARBs has been shown to reduce collagen production 
and increase the elastin to collagen ratio (Shahin et al., 2012). A meta-analysis demonstrated that 
the use of ARBs and ACE inhibitors reduced the risk of myocardial infarction, stroke, 
cardiovascular mortality and total mortality in uninjured subjects (Reboldi et al., 2008), 
suggesting that the excessive ANG II production may lead to an increased risk of CVD.  
CVD has developed as a leading cause of mortality in individuals with chronic SCI and; 
furthermore, morbidity due to CVD occurs at an earlier age in the SCI compared to the uninjured 
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population (Jonathan Myers, Matthew Lee, & Jenny Kiratli, 2007). In the general population, 
CVD risk is attributed to age, hypertension, physical (in)activity level, body composition and 
dyslipidemia (Cragg, Noonan, Krassioukov, & Borisoff, 2013; Sowers, Epstein, & Frohlich, 
2001); however, there is evidence to suggest that these risk factors do not fully explain the 
increased incidence of CVD in the SCI population (Cragg et al., 2013). A possible, previously 
not considered, risk factor for this population could be the overuse of ANG II, since individuals 
with SCI have a heightened reliance on the RAAS to maintain BP homeostasis (Mathias, 
Christensen, Frankel, & Peart, 1980; Mathias, Frankel, Davies, James, & Peart, 1981; Wecht et 
al., 2005). Renin was shown to be higher during resting conditions in individuals with SCI 
compared to uninjured controls, indicating that upregulation of the RAAS is not dependent on 
the integrity of the SNS (Johnson, Park, & Frankel, 1971; Mathias et al., 1975; Mathias et al., 
1980; Mathias et al., 1981). Goothius and colleagues (2010) demonstrated an increase in ANG II 
during baseline in SCI compared to uninjured controls, however, ANG II levels were not 
excessively high (Groothuis et al., 2010). Additionally, their results showed that ANG II 
explained increased leg vascular resistance, but not forearm resistance, which may be because 
AT1 receptors have increased sensitivity or density in the legs compared to the arms (Groothuis 
et al., 2010). This concept was further studied in rats with a chronic spinal transection at T11 
demonstrating increased reactivity of vascular muscle to ANG II (Al Dera & Brock, 2014). Due 
to dysfunction of supraspinal SNS regulation to the peripheral vasculature, the RAAS may play a 
greater role in regulating vascular resistance (Al Dera & Brock, 2014) for maintenance of BP 
homeostasis. 
The ANS is responsible for postural homeostasis; therefore, with impairment to the 
system, BP will fall after moving to an upright position (Fedorowski et al., 2009). According to a 
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Consensus statement from the American Autonomic Society and American Academy of 
Neurology, OH is defined as a decrease in systolic BP (SBP) of 20+ mmHg and/or a fall in 
diastolic BP (DBP) of 10+ mmHg within 3-minutes of moving from supine to the upright 
position, with or without symptoms (Neurology, 1996). In an uninjured person, movement to the 
upright position reduces BP due to pooling of blood in the lower extremities. This is sensed by 
the baroreceptors which elicit withdrawal of tonic vagal (PNS) tone to the SA-node and 
activation of SNS vasomotor tone via descending spinal tracts, causing vasoconstriction and 
increase in cardiac rate and contractility resulting in a rise in BP (Benvenuto & Krakoff, 2011; 
Claydon, Steeves, & Krassioukov, 2006). In the uninjured population this quick feedback loop 
results in non-significant changes in SBP, slight increases in DBP and a corresponding increase 
in HR during an orthostatic challenge (Freeman et al., 2011).  
After a SCI, the SNS arm of the baroreceptor reflex, is interrupted or lost, resulting in 
alteration in orthostatic BP control (Claydon & Krassioukov, 2008; Phillips, Cote, Bredin, 
Krassioukov, & Warburton, 2012). Generally, lesions above T6 experience orthostatic instability 
due to SNS dysfunction, which leads to the inability to adequately adjust vasomotor tone  and 
maintain BP (Claydon et al., 2006). Individuals with injuries above T6 would be expected to 
have some degree of impaired vascular innervation to the splanchnic bed and the lower 
extremities, which holds a majority of blood volume (Garstang & Miller-Smith, 2007; Sahota, 
Ravensbergen, McGrath, & Claydon, 2012). Additionally, the lack of skeletal muscle pump may 
contribute to increased blood pooling in the lower extremities venous vasculature resulting in 
lower venous return thereby restricting stroke volume (Claydon et al., 2006; Krassioukov & 
Claydon, 2006). With higher LOI already demonstrating low resting BP (West et al., 2012), a 
further decline in BP during orthostatic re-positioning can result in symptoms of cerebral 
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hypoperfusion including: dizziness, weakness, light-headedness, blurred vision, pre-syncope and 
syncope, which can adversely impact the activities of daily living (Claydon et al., 2006; Garstang 
& Miller-Smith, 2007; Phillips, Krassioukov, Ainslie, Cote, & Warburton, 2014).  
Another facet of the underlying pathophysiology of OH following SCI is decreased 
resting catecholamine levels. The SNS regulates the response of releasing circulating hormones 
from the adrenal medulla (S. Kirshblum & Campagnolo, 2011, p. 138). Measuring free plasma 
catecholamines correlates with SNS integrity due to their short half-life (Claydon, Hol, Eng, & 
Krassioukov, 2006; Kirshblum & Campagnolo, 2011).  Orthostatic BP responses are related to 
circulating levels of norepinephrine (NE), and lower levels of NE are associated with an 
increased incidence of OH in persons with SCI (Claydon & Krassioukov, 2008). Relevant 
literature has shown decreased plasma epinephrine and NE concentration in individuals with 
cervical lesions compared to individuals with thoracic injuries and uninjured controls  
(Krassioukov et al., 2009; Mathias et al., 1975; Schmid, Huonker, Barturen, et al., 1998; Schmid, 
Huonker, Stahl, et al., 1998). Specifically, after 10 minutes of an orthostatic challenge, NE 
increased 14% in individuals with high cord lesions, compared to 115% increase in uninjured 
controls (Mathias et al., 1975). Additionally, the investigators reported that epinephrine was 
unaffected by the change in posture in individuals with cervical lesions (Mathias et al., 1975). 
The small change in catecholamines after orthostatic repositioning in persons with tetraplegia is 
due to impaired supraspinal control of the sympathetic efferent pathways (Mathias et al., 1980) 
and consequently, results in the inability to increase vasomotor tone and maintain BP (V. 
Claydon et al., 2006) 
With a greater fall in BP during OH in individuals with tetraplegia, the use of the RAAS 
is critically important to maintain BP; however, the pathological effects of ANG II may supplant 
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the benefits. Renin was shown to increase in individuals with tetraplegia during head-up tilt 
(HUT), an orthostatic challenge, at a much quicker and higher rise compared to uninjured 
controls (Mathias et al., 1975; Mathias et al., 1981; Popa et al., 2010); conversely, one study 
demonstrated that renin was not increased with HUT in individuals with tetraplegia, which the 
investigator explained may be due to large inter-subject variability (5 of the 7 subjects were 
motor and sensory incomplete) (Wecht et al., 2005).  In individuals with cervical injuries, the use 
of anti-hypotensive agents (midodrine and L-NAME) to normalize BP may reduce orthostatic 
dependency on the RAAS because plasma renin and aldosterone levels after HUT were 
comparable with supine levels during HUT and there was a significant inverse association 
between mean arterial pressure and renin responses to HUT (Wecht et al., 2011).  This finding 
may have significant clinical implication because the level of dependency on the RAAS may be 
reduced if BP is maintained during an orthostatic challenge (Katzelnick et al., 2017; Jill M 
Wecht et al., 2011). Additionally, Groothuis et al. (2010) demonstrated that ANG II contributed 
to increased supine leg vascular resistance in individuals with thoracic injuries (T4-T12) but did 
not explain the increased vascular tone during 30°of HUT. This disparate finding may relate to 
an insufficient orthostatic stress (30°) since higher degrees of HUT (45 and 60 degrees) have 
been shown to place greater strain on SNS (Phillips et al., 2014; Steinback et al., 2005; Jill M 
Wecht et al., 2009). Additional evidence is needed to demonstrate if renin and ANG II levels are 
increased during an orthostatic provocation in persons with SCI and if so, how this might 
contribute to increased vascular resistance and AS.   
AS has been identified as an independent risk factor for CVD (Cavalcante et al., 2011; Azra 
Mahmud & Feely, 2004; Shahin et al., 2012) and is one of the earliest detectable indicators of 
adverse vascular changes (Cavalcante et al., 2011). The primary function of the arterial system is 
15 
 
to deliver blood from the heart to the peripheral tissues and to dampen intermittent left ventricle 
ejection pressure thereby maintaining a steady flow of nutrient rich blood to vital organs 
(London & Pannier, 2010). The ability of the arteries to accommodate changes in blood volume 
during the cardiac cycle depends on the ratio of elastic to collagen fibers (Oliver & Webb, 2003). 
In a more compliant arterial system, reflected waveforms return to the aorta from the periphery 
during diastole, increasing DBP and augmenting coronary artery blood flow, which translates 
into reduced AS. Conversely, in a relatively stiffer arterial system, due to increased collagen and 
lumen diameter thickness (Duprez, 2006; Safar, Blacher, & Jankowski, 2011), reflective 
waveforms return to the aorta during systole, thereby augmenting ventricular work, limiting 
coronary artery perfusion and increasing AS (London & Pannier, 2010; Oliver & Webb, 2003). 
In the general population, AS is influenced by two principal factors: age and BP (Cecelja & 
Chowienczyk, 2009; Hansen, 2010; London & Pannier, 2010). Both elements cause elastic fibers 
to spilt, fracture and become fragmented after repetitive stress cycles, and cause elastin fibers to 
degenerate while collagen fibers increase. Stiffening of the vascular walls with aging is 
associated with increased hemodynamic load, hormonal changes, glycemic diet and overall 
decline in the structure and function of the vascular system (Shirwany & Zou, 2010). 
Augmentation of AS with age occurs gradually and this trajectory is similar in males and females 
(Benetos et al., 2002). A stiffening vasculature works to increase SBP by amplifying the initial 
pressure wave generated during left ventricular ejection, accelerating return of the  reflected 
wave from the periphery during systole and, reducing pressure during diastole (London & 
Pannier, 2010; Shirwany & Zou, 2010). This adversely impacts cardiac function by increasing 
myocardial oxygen demand while hindering ventricular ejection and comprising coronary 
perfusion (Benetos et al., 2002; London & Pannier, 2010).  
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Vascular remodeling is largely accomplished within 3 weeks following SCI (C4-L1) and 
these rapid changes include a 25% reduction in femoral artery diameter and lower extremity 
blood volume, and doubling of shear stress rate (de Groot, Bleeker, van Kuppevelt, van der 
Woude, & Hopman, 2006). Additionally, Thijseen and colleagues (2012) observed gradual 
increases in arterial wall thickness within 24 weeks after injury which was present and similar 
below (femoral artery) and above (carotid artery) the spinal lesion, demonstrating that arterial 
wall thickness is systemic and not localized (Thijssen et al., 2012). Increased AS has been 
documented in individuals with SCI compared to age-matched uninjured controls (Huang, May-
Kuen, et al., 2013; Katzelnick et al., 2017; Miyatani et al., 2009; Phillips et al., 2012; Thijssen et 
al., 2012; Wecht, Weir, DeMeersman, Spungen, & Bauman, 2004); however, there is 
controversy comparing stiffness in individuals with tetraplegia and paraplegia.  
Increased AS was reported in individuals with thoracic cord lesions (T2-T12) compared to 
those with high cord lesions (C2-C8) (Miyatani et al., 2014). This finding is surprising because 
most of the risk factors (BP lability, deconditioning and impaired SNS) for increased central AS 
is reduced in those with paraplegia individuals (Popa et al., 2010; Claydon et al., 2006; West 
2012), but may be contributable to categorical segregation by level of motor impairment (i.e., 
paraplegia versus tetraplegia) rather than by level of sympathetic cardiovascular interruption ( 
i.e., above versus below T6). Another study reported no difference in AS between individuals 
with high and low cord lesions, which may be due to variability in duration of injury (3 to 518 
months) (Wu et al., 2017). Recently, our group was the first to document heightened stiffness in 
high cord lesion (C3-T5) compared to low thoracic lesions (T7-T12) (Katzelnick et al., 2017). In 
this study, we measured AS by augmentation index at the radial artery, whereas in the prior 
report (Miyatani et al., 2014) PWV was determined at the carotid to the femoral artery. 
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Individuals with low cord lesions would be expected to have full sympathetic innervation of the 
radial artery, compared to individuals with high cord lesions who have partially to complete 
decentralized autonomic control. Further investigation is needed to clarify and ascertain the 
relationship between lesion level and AS.  
There is evidence supporting a direct linear association between AS and LOI, with AS 
increasing with ascending LOI (Katzelnick et al., 2017). In this same study, the investigators 
reported that individuals with increased AS reported experiencing OH (Katzelnick et al., 2017); 
and furthermore, Currie et al. (2019) demonstrated that hypotensive events within 24-hour period 
were associated with increased arterial stiffness in individuals with injuries to T6 and above. 
This suggests that BP instability may play a role in causing structural vascular adaptations AS 
post SCI (Currie et al., 2019; Phillips et al., 2014). A recent study demonstrated increased AS 
during HUT in individuals with cervical injuries compared to uninjured controls (Phillips et al., 
2014); conversely, Huang and colleagues (2013) showed no significant group difference in AS in 
a similar study design (Huang, Wong, et al., 2013). This discrepancy may be due to the 
differences in duration of injury (5-144 weeks vs. 3-289 months) and completeness of injury 
(Phillips et al. all motor complete (AIS A & B) vs. Huang et al. AIS A, B, C & D). Interestingly, 
our team recently demonstrated that there was significant inverse relationship between seated 
SBP and AS (Katzelnick et al., 2017); and furthermore, Phillips et al. (2014) demonstrated that 
the increase in AS during HUT in SCI was reversed by a pre-treatment of midodrine 
hydrochloride, an alpha-adrenergic agonist. We speculate that this may be related to a reliance on 
RAAS for orthostatic BP maintenance, which may have detrimental effects on AS. Although 
increased AS has been reported in individuals with SCI, controversy abounds and additional 
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evidence is needed to gain a better understanding of impact of morphologic and physiologic 
vascular adaptations that occur following SCI on orthostatic BP regulation and AS.  
A variety of non-invasive testing modalities are used to accurately assess and track AS 
(Jae, Heffernan, Lee, & Fernhall, 2008). Ultrasound techniques can be used to assess vessel 
distention and derived stiffness indexes or flow waveforms (Townsend et al., 2015).  These 
modalities (i.e. flow mediated dilation, carotid intima-media thickness) are generally more 
expensive and require a high level of technical skill (Stoner, Credeur, Dolbow, & Gater, 2015). 
MRI-based approaches can examine almost any vessel and provide more accurate distance and 
area measurements, but these approaches are very expensive and impractical (Townsend et al., 
2015). Applanation tonometry has been used extensively in the literature because it is relatively 
inexpensive, requires a short testing time, and does not demand highly technical skill levels 
(Stoner et al., 2015; Townsend et al., 2015).  Pulse wave velocity (PWV), which may be assessed 
using applanation tonometry, is calculated by measuring the distance between two vessels (i.e. 
carotid, brachial, radial, femoral, ankle) and the pulse wave arrival time at each vessel (R wave 
of ECG) (Stoner et al., 2015).  
Assessment of aortic PWV (aPWV, using the carotid and femoral arteries) is considered 
to be the gold standard technique (Townsend et al., 2015) because of its high reliability and 
validity. Using the SphygmoCor CPV system (AtCor Medical Pty Ltd., West Ryde, NSW., 
Australia), aPWV was validated against invasive measurement of aPWV from the ascending 
aorta to the iliac bifurcation in 135 participants (Weber et al., 2009). The mean difference 
between the invasive aPWV and noninvasive aPWV was -0.2 m/s, (Spearman’s R = 0.73, 
p<0.0001) (Weber et al., 2009). Additionally, the reproducibility of the system for within-
observer variability was 0.07 ± 1.7 m/s and for between-observer difference was 0.30 ± 1.25 m/s 
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(Wilkinson et al., 1998). Measuring aPWV along the aortic and aorto-iliac pathway is most 
appropriate because the aorta is the principal cushioning artery and is responsible for the 
pathophysiological effects of AS (Stephane Laurent et al., 2006; London & Pannier, 2010).   
Summation and Relevance 
 In summary, medical advances have contributed to increased life expectancy in 
individuals with SCI; however, CVD has become a leading cause of morbidity and mortality in 
individuals with chronic SCI (Cragg et al., 2013; Krause, Cao, DeVivo, & DiPiro, 2016; LaVela 
et al., 2012). Predominantly sedentary lifestyles (Stoner et al., 2015), ANS dysfunction (Cragg et 
al., 2013) and heightened inflammatory processes (LaVela et al., 2012) may contribute to the 
increased incidence and premature development of CVD in the SCI compared to the uninjured 
population (Myers, Lee, & Kiratli, 2007). It is well recognized that CVD risk increases with age, 
hypertension, adverse body compositional changes and physical inactivity; however, there is 
support to suggest that these traditional risk factors may not fully explain the early onset of CVD 
in the SCI population (Cragg et al., 2013; Miyatani et al., 2014). In fact, it has been demonstrated 
that PWV was increased in SCI participants compared to healthy uninjured controls after 
matching for age, body composition and activity levels (Phillips et al., 2014).  Additionally, 
individuals with tetraplegia demonstrated heightened CCA intima-media thickness compared to 
individuals with paraplegia, even with similar inflammatory profile (Matos-Souza et al., 2010). 
Both of these studies suggests that other factors may mediate increases in AS in SCI population, 
and specifically, individuals with high-level injuries. 
 Individuals with tetraplegia rely heavily on the RAAS for both short- and long-term 
regulation of orthostatic BP ( Wecht et al., 2011), which may play an important role in 
determining AS in this population (Katzelnick et al., 2017; West et al., 2013).  However, the 
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association between ANG II levels and AS during an orthostatic provocation has not been 
studied in the SCI population. Understanding the contribution of activation of the RAAS and 
elevated levels of ANG II to the development of premature and heightened AS in the SCI 
population will guide clinical treatment of hypotension and OH, which may lead to improved BP 
regulation and preservation of cardiovascular health and longevity. 
Theoretical Framework 
 Asymptomatic OH occurs in up to 50% of individuals with chronic tetraplegia ( 
Krassioukov et al., 2009; Phillips et al., 2012) and may lead to pre-syncopal symptoms that 
include light-headedness, dizziness, blurred vision, fatigue, nausea, dyspnea, which adversely 
impacts their quality of life, hindering their ability to perform orthostatic maneuvers during 
routine daily activities and mobilization (Claydon et al., 2006; Krassioukov et al., 2009; Phillips 
et al., 2012). Uninjured individuals with  persistent and episodic OH have been shown to be at an 
elevated risk of stroke (Benvenuto & Krakoff, 2011; Eigenbrodt et al., 2000), and it has been 
speculated that OH may explain the 2-3 fold increase of stroke in the SCI population (Cragg et 
al., 2013; Phillips et al., 2012).  Additionally, OH is associated with cognitive deficits in the 
uninjured population (Novak & Hajjar, 2010; Yap, Niti, Yap, & Ng, 2008), which may 
contribute to, in addition to chronic hypotension, documented deficits in memory, attention, 
processing speed, and executive function in hypotensive individuals with SCI (Jegede et al., 
2010; Wecht et al., 2011). Several large population-based studies reported increased AS may 
contribute to cognitive decline with aging in the uninjured population (Pase et al., 2010). 
Specifically, three studies have documented that association between increased AS and cognitive 
decline in global cognitive function (mini-mental state examination score) after co-varying for 
age, MAP (mean arterial pressure), education level, and CVD (Elias et al., 2009; Scuteri et al., 
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2007), as well as in verbal learning, delayed recall, and memory (Waldstein et al., 2008). Thus, 
premature changes in vascular morphology may predispose individuals with SCI to cognitive 
deficits.  Furthermore, increasing vascular stiffness is associated with an increased risk of CVD 
in the general population (Cecelja & Chowienczyk, 2012; Mitchell et al., 2010; Vlachopoulos et 
al., 2010). Recent literature reported that more rostral level and more complete SCI are 
associated with greater risk of all CVD (Groah, Weitzenkamp, Sett, Soni, & Savic, 2001).  It is 
imperative that we identify the possible association between increased reliance on the RAAS for 
BP maintenance and the increased incidence of AS in persons with SCI with the goal of reducing 
CVD progression and improving cognitive function in this highly vulnerable population.  
Gaps 
Based on recent literature and our theoretical model, convincing evidence is needed to 
demonstrate that liberal use of anti-hypotensive medications in individuals with SCI might 
mitigate reliance on the RAAS and reducing levels of ANG II during orthostasis. Using this type 
of medication would expect to improve BP homeostasis, thereby lessening the symptoms 
associated with cerebral hypoperfusion and improving long-term cardiovascular and cognitive 
outcomes.  As of today, clinical practice guidelines recommend that only individuals who 
experience symptomatic OH be prescribed anti-hypotensive medications; however, the 
homeostatic maintenance of BP, regardless of symptoms, may be critical in promoting long-term 
health and independence in the SCI population. Secondly, sufficient evidence is lacking to 
describe the association between orthostatic BP changes and the increased incidence of AS in the 
SCI population. Investigation into this association have consisted of heterogeneous study 
subjects with varying levels, severities and durations of injury, which would be expected to 
differentially impact the SNS response to orthostasis.  Adequate plasms catecholamine responses 
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during HUT would improve orthostatic BP responses thereby limiting use of the RAAS.   
Moreover, during the acute phase of SCI (<1 years post injury), the morphology of the arterial 
vessels is changing rapidly; therefore, it may be more effective to measure AS after the initial 
paralysis and atrophy of the muscles. Lastly, there is no research demonstrating if the overuse of 
RAAS, specifically ANG II, contributes to the increased AS in the SCI population. Recent 
literature has stated that there may be additional risk factors other than the traditional ones that 
explain the increased CVD in this population, thus the over production of ANG II may explain 
the morphologic vascular mal-adaptations that occur following a SCI.  
Scientific Relevance 
A heightened prevalence of CVD is now the leading cause of morbidity and mortality in 
the SCI population, and ANS dysfunction underlines several irregularities that contribute to 
CVD (Myers et al., 2007). It has been speculated that persons with chronic SCI have accelerated 
cardiovascular aging (Myers et al., 2007; Yarar-Fisher et al., 2017) due to sedentary lifestyle 
(Stoner et al., 2015), increased inflammatory processes (La Favor, Hollis, Mokshagundam, & 
Olive, 2011; Sherri L LaVela et al., 2012), and cardiovascular autonomic dysregulation (. 
Claydon & Krassioukov, 2008; Cragg et al., 2013; Myers et al., 2007; Nier & Hansen, 2017). 
Recent literature speculates that additional risk factors are likely to contribute to premature CVD 
in the SCI population, and it has been shown that individuals with SCI have a 2 to 3 fold increase 
in the odds of developing heart disease and stroke (Cragg et al., 2013). Additionally, in the 
general population, a 1.0 m/s increase in aPWV translates to a 15% increase in CVD risk 
(Vlachopoulos et al., 2010) and consistent evidence demonstrates that individuals with SCI have 
an accelerated aPWV that is increased 2-3 m/s compared to uninjured individuals (Lee, Phillips, 
& Krassioukov, 2017; Miyatani et al., 2009; Phillips et al., 2012). Thus, it cannot be over 
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emphasized that health care providers are faced with significant challenges associated with 
prevention, diagnosis and management of older individuals with SCI at heightened risk for 
development of chronic diseases (Groah et al., 2001). Identifying the potential contribution of 
increased reliance on the RAAS, and ANG II, for orthostatic BP hemostasis in the SCI 
population and the effect on AS will help clinicians understand and screen for additional risk 
factors that contribute to CVD.  
Summary 
 As a consequence of decentralized SNS, individuals with high level lesions are 
hypotensive with episodic falls in BP during orthostasis (Kirshblum & Campagnolo, 2011; A. 
Krassioukov, 2009).  OH after SCI is thought to be related to baroreflex dysfunction, reduced 
skeletal muscle pump, and diminished catecholamines, which leads to an increased reliance on 
the RAAS for BP maintenance (S. Kirshblum & Campagnolo, 2011; Jill Maria Wecht & 
Bauman, 2018). The RAAS has been increasingly recognized as a major risk factor in the 
progression of atherosclerosis and increasing CVD risk in the uninjured population (Williams, 
2001). Specifically, ANG II has been shown to modify the structure of the arteries by altering the 
ratio of collagen and elastic fibers in the vasculature (Shahin et al., 2012). Therefore, due to 
increased dependency on the RAAS to maintain orthostatic BP homeostasis (Wecht & Bauman, 
2018), individuals with SCI, particularly those with high cord lesions, may be at increased risk 
for premature and increased AS.  
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Chapter III 
 
METHODS 
 
 
 
Participants 
All subjects (N=33) were between the ages of 28-69 years with no known history of 
CVD, diabetes mellitus, and hypertension. All were current nonsmokers for a minimum of 1 year 
before investigation and were not receiving medications known to affect autonomic 
cardiovascular function. Subjects with high-level injury (HIGH-SCI; n=11; C4-T1) and low-
thoracic injury (LOW-SCI; n=11; T6-12) were injured for at least 1 year, chronically wheelchair 
bound, and ASIA grade A, B or C. The uninjured control subjects (n=11) were matched for age, 
height, and weight to the subjects with SCI.  
Individuals with SCI will be recruited from the Northern New Jersey SCI Model System 
database, which currently contains over 1000 people with traumatic SCI. Additionally, uninjured 
control subjects were recruited from the local community and hospital personnel via study 
solicitation flyer distribution. Participants were screened before study for inclusion and exclusion 
criteria. The Institutional Review Board for Human Studies of Seton Hall University, James J. 
Peters Veterans Affairs Medical Center and Kessler Foundation granted approval for the study, 
and informed consent was obtained before study initiation. 
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Procedure 
 All subjects were told to avoid caffeine, alcohol and exercise for at least 12 hours before 
testing and to be well hydrated. Participants were asked to remain seated in a testing chair to 
collect 5 minutes of seated resting hemodynamic data. After, subjects were asked to transfer to 
the tilt table and remained in the supine position for 10 minutes prior to baseline supine 
hemodynamic measurement, PWV, and first blood draw. Subjects were then progressively tilted 
from supine to 30 º, 45 º, and 60 º for 10 minutes at each tilt. A 3-lead ECG (Impedance 
Pneumograph, model RESP 1: UFI, Morro Bay, CA, USA) was used to monitor beat-to-beat HR, 
with ECG electrodes placed at the right and left mid-axillary lines in the 5th intercostal space and 
at the right anterior axillary line. Before placing each electrode, each site was cleaned with 
alcohol pads. Continuous BP was assessed at the finger using photoplethysmograph (Finometer 
PRO, Finapres Medical Systems B. V., Netherlands) and at the brachial artery with manual 
auscultation (Series Wall Mobile Sphygmomanometers, Trimline Medical Products, Raritan, NJ, 
USA).  Mean arterial pressure (MAP) was calculated as diastolic blood pressure (DBP) + 
1/3(SBP-DBP). Continuous HR and BP were viewed and monitored in real-time and were stored 
on a desktop hard drive for offline analysis. HR and BP signals were collected at a sample rate of 
500 Hz/channel with a 12-bit analog-to-digital converter (DAQcard-700, National Instruments, 
Austin, TX) and were analyzed using customized programs written with LabVIEW graphical 
software for instrumentation (National Instruments). In each position and tilt angle, HR and BP 
were measured and averaged over 5 minutes to use for analysis. At 60 º, second blood draw was 
collected.  
Tilt Table 
26 
 
 The tilt table was padded and motorized. Restraining straps were used on the lower 
extremities and trunk to ensure subject safety during higher inclinations of HUT and to avoid 
lower-extremity muscle contractions in the control subjects. The straps were wide and padded for 
subject comfort and to insure that stimulation of sympathetic spinal reflexes was not evoked. The 
orthostatic provocation included a progressive HUT from supine position to 30º, 45 º and 60 º for 
10 minutes at each angle of tilt. Adjustment of the tilt table to each angle was accomplished in 
less than 5 seconds, and subjects were questioned at each angle of tilt regarding symptoms of 
syncope (i.e., blurry vision, dizziness, light-headedness, or nausea).  
Pulse Wave Velocity  
 After supine hemodynamic recording, PWV was measured using the SphygmoCor CPV 
system (AtCor Medical Pty Ltd., West Ryde, NSW., Australia) at the carotid and femoral sites. 
The average 5-minute resting supine BP was entered into the software. A 3-lead ECG designed 
for the system measured the R-R wave with the ECG electrodes located just below the supra-
sternal notch, on the chest over the sternum and just above the left hip on the chest. The carotid 
and femoral arteries were palpated for the strongest pulse and then measured from the 
participant’s supra-sternal notch to each artery.  The PWV measurement was taken in two steps: 
a tonometry reading of site A (carotid artery) with an ECG signal simultaneously recorded 
captured after 10 seconds of good data, followed by a 10 second reading of site B (femoral 
artery) with an ECG signal (Research Applications Manual). Good quality PWV measurement 
was accepted if the standard deviation was low, defined as the difference in HR between site A 
and B measurements more than 5 beats per minute.  
Hormonal Assessments  
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 Active plasma renin (surrogate measure of ANG II) and norepinephrine levels were 
assessed by immunoassay. Antecubital venous blood samples were collected at supine and at the 
60 º. Blood samples were immediately placed in an ice bath for subsequent centrifugation. 
Plasma and serum were separated from blood products and frozen at -30 º for subsequent batched 
analysis.  
Data Analysis 
 Statistical analyses were performed using SPSS 16.0 (SPSS, Inc., Chicago, Illinois, USA) 
software. All continuous variables were reported as mean plus or minus standard deviation 
(mean ± standard deviation), unless otherwise stated. Data were assessed for normality using 
Kolmogorov-Smirnov test and P-P plots. Pearson or Spearman’s corrleations for normal and 
non-normal distributed data were used to examine if there was an influence of change of 
orthostatic SBP on the RAAS responses to orthostasis and relationship between PWV and 
change in renin. Univariate analysis of variance (ANOVA) were used to determine group 
differences in hemodynamics, orthostatic reliance on the RAAS hormonal assessment (renin) and 
supine PWV. Tukey HSD post hoc tests were used if the omnibus interaction effect was 
significant. The level of statistical significance was set at α less than 0.05. 
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Chapter IV 
 
 
RESULTS & DISCUSSION 
 
 
 
 The first aim was to determine group differences in hemodynamics and hormone 
concentrations among the groups. We hypothesized that SBP would decrease during HUT in 
HIGH-SCI, while SBP would remain unchanged during HUT in LOW-SCI and able-bodied 
controls. In addition, we predict that plasma renin levels will be significantly greater at HUT in 
HIGH-SCI compared to LOW-SCI and able-bodied controls.  
Our second aim was to investigate group differences for change in hemodynamics and 
hormones from supine rest to 60-degree HUT. We hypothesized that individuals with HIGH-SCI 
would have a greater change in SBP compared to LOW-SCI and able-bodied controls. Similarly, 
we hypothesized that HIGH-SCI group would have an increased change in renin levels, while 
renin levels would be unchanged in LOW-SCI and able-bodied controls.  
Thirdly, we investigated the influence of the change in BP and change in plasma renin 
from supine rest to 60-degree HUT. We hypothesized that individuals with HIGH-SCI would 
have a positive relationship between the change in BP and change in renin, while there would be 
no relationship between the two variables in the LOW-SCI group and able-bodied controls.  
Lastly, we aimed to determine if increased reliance on the RAAS for orthostatic BP 
regulation contributes to differences in AS. We hypothesized that there would be a positive 
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relationship between change in renin and AS in HIGH-SCI, while there would be no relationship 
between the two variables in LOW-SCI and able-bodied controls.  
Participant Characteristics 
 The demographics of the study sample are presented by group (Table 1). The groups did 
not differ significantly for age, height, weight or body mass index. In addition, the SCI groups 
did not differ in AIS, DOI and age at time of injury.  
Hemodynamics 
 Two-way ANOVA models were used to determine main and interaction effects for group 
(able-bodied controls, HIGH-SCI, LOW-SCI) and orthostatic position (supine, HUT) in 
hemodynamics and plasma renin.  
Heart Rate  
There were significant main effects for group (F(2,120)= 5.90, p=.01, ω2= .05) and 
position (F(3,120)= 11.69, p<.001, ω2= .19); however, the interaction effect was not significant.  
Systolic Blood Pressure 
 While the main effect for group was significant ((F(2,120)= 6.48, p=.002, ω2=.07); the 
main effect for position and the interaction effects were not significant   
Diastolic Blood Pressure 
 There was a significant group main effect (F(2,120)= 11.51, p<.0001, ω2=.14); however, 
the main effect for position and the interaction effect were not significant.  
Plasma Renin Responses 
 There was no significant main or interaction effects for plasma renin. 
Arterial Stiffness 
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One-way ANOVA was used to determine a significant group main effect for the AS 
(p<.0001; eta2 (η2) =0.67).  Pairwise comparisons (Tukey HSD procedure) indicated that AS was 
significantly increased in HIGH-SCI (HIGH-SCI: 8.81 ± 1.91 m/s) and LOW-SCI (LOW-SCI: 
7.36 ± 1.58 m/s) groups compared to age-matched controls (5.53 ± 0.95 m/s; p=.04). AS was 
higher in the HIGH-SCI group compared to LOW-SCI; however, not significantly different.  
Linear regression models were used to determine the effect of age and injury 
characteristics on PWV among the groups.  Although age did not contribute significantly to 
PWV in the groups with SCI, age accounted for 83% of the variance in PWV in the control 
group (r2=0.83; p=.002); In addition, there was no relationship between DOI, level of lesion and 
AS in SCI groups,   
Change in Hormonal Response 
There was a significant main effect for the change in renin from supine to 60 degree 
HUT, F(2,30)=6.31, p=.01, ω2=.25.  Pairwise comparisons (Tukey HSD procedure) indicated 
that individuals with HIGH-SCI had significantly higher changes in renin levels (11.54 ± 12.49 
pg/ml) compared to individuals with LOW-SCI (0.47 ± 5.67 pg/ml, p=.01) and able-bodied 
controls (1.22 ± 3.45 pg/ml, p=.02).  
Orthostatic BP and Renin 
 Multiple regression analysis on the change in SBP and plasma renin was performed in the 
total study sample (n=33). The results suggest that the model significantly improved our ability 
to predict SBP, F(2,30)=7.61, p=.002. Change in renin was a significant predictor to the change 
in SBP and contributed to the model, t(30)=-3.90, p<.001; however, the group predictor is not 
significant and did not contribute to the model, t(30)=0.26, p=.80. The change in plasma renin 
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accounted for 35% of the variance in the changes in SBP with tilt in the total study sample (r2= 
0.347; p=.002).  
Arterial Stiffness and Renin 
Multiple regression analysis on AS and change in renin was performed in the total study 
sample (n=33). Assumptions were met to perform multiple regression. The results suggest that 
the model significantly improved our ability to predict AS, F(2,30)=19.66, p<.0001. The group, 
t(30)=3.32, p=.002, and change in renin, t(30)=5.42, p<.0001 were significant predictors to AS 
and contributed to the model. Relationship between change in plasma renin and AS was 
significant in the total study sample (r2= 0.57; p<.0001).  
Separate regression analysis by group were then used. Assumptions were met to perform 
Pearson’s correlation for all three groups. As hypothesized there was a significant relationship 
between AS and change in plasma renin in HIGH-SCI, r = .62, p =.04, while there was no 
relationship in able-bodied controls, r=.04, p= .91.  
For LOW-SCI, we performed Grubb’s test to identify an outlier in the group. The 
absolute z score of the change in renin (2.91) was significantly higher than the upper significance 
levels at sample size 11, so that score is an outlier (Grubbs & Beck, 1972).  There was no 
significant relationship between the AS and change in plasma renin in individuals with LOW-
SCI, r=.18, p=.62.  
Discussion 
As per design, the controls were age, height, weight and body mass index matched to the 
SCI participants. In the present study, AS was measured by PWV, and was compared in age-
matched individuals with HIGH-SCI, LOW-SCI and able-bodied controls. AS was increased in 
those with SCI compared to the uninjured controls; however, there were no differences in AS in 
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the SCI groups. Secondly, the change in orthostatic BP from rest to 60-degree HUT was 
inversely associated to the change in plasma renin levels in the total sample. Furthermore, the 
change in plasma renin levels during HUT was directly related to AS in the HIGH-SCI group.  
Arterial Stiffness by Group 
 It is well appreciated that the natural aging process increases AS, and the values of AS in 
the control group were similar to those previously reported for healthy individuals (Boutouyrie 
and Vermeersch, 2010). However, the association between age and AS was not significant in our 
participants with SCI, regardless of the level of lesion, which is in agreement with our previous 
study (Katzelnick et al., 2017). In addition, DOI, age at injury and level of lesion did not play a 
role in AS. Again, this is similar to our previous report (Katzelnick et al., 2017); however, this is 
in contrast to a recent study that reported a correlation between stiffness index and duration of 
injury (Wu et al., 2016). The disparity between our findings and those previously reported may 
be attributed to inclusion of individuals with acute and chronic injuries (3-518 months) in the 
prior report and differing methodology (i.e. stiffness index by digital volume pulse vs. PWV). 
It has become increasingly clear that individuals with SCI have increased AS compared 
to age-matched able-bodied controls (Katzelnick et al., 2017; Phillips et al., 2012; Huang et al., 
2013; Miyatani et al., 2014; Lee et al., 2017; Wecht et al., 2004). Conversely, the relationship 
between level of lesion and AS is still not certain. We previously reported that AS (measured by 
augmentation index at the radial artery) was increased in HIGH-SCI compared to LOW-SCI 
(Katzelnick et al., 2017); however in the present study, we found no difference in PWV between 
the SCI groups. This may be attributed to differing methodology. In the present study, PWV was 
measured at the carotid and femoral arteries, which is gold standard measurement for AS; 
however, in our previous work, the augmentation index was performed at the radial artery, where 
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we would expect to have full sympathetic innervation in individuals with low cord lesions, but 
would be partially to completely decentralized among those with high cord lesions. Although not 
significant, individuals with HIGH-SCI had slightly higher AS than LOW-SCI group. With a 
larger sample size, we may see a significant difference between the two groups. Miyatani et al. 
(2014) reported higher AS in individuals with paraplegia (T1-T12) compared to individuals with 
tetraplegia (C2-C8). This is highly surprising given that most risk factors for increased AS is 
increased in those with higher level injuries including BP liability, physical inactivity, and 
impaired SNS function (Lee et al., 2017; West et al., 2012; Popa et al., 2010; Weaver et al., 
2012). Additionally, Miyatani and colleagues included all levels of thoracic injuries in their 
paraplegia group, including those that have control of their splanchnic bed and those who do not. 
It is essential to understand that within the SCI population, there is a large degree of 
cardiovascular variability that is directly related to the specific level of injury.  
 AS is recognized as an independent predictor for CVD (Vlachopoulos et al. 2010), and 
because CVD is the leading cause of mortality in the SCI population (Craigg et al.,), AS may 
serve as a vital prognostic tool (Currie et al., 2019). An individual presenting with AS of greater 
than 10 m/s is considered at elevated risk of a cardiovascular event (Van Bortel et al., 2011), and 
in our sample, we have three individuals with HIGH-SCI that have a AS above 10 m/sec. 
Furthermore, we compared the AS values in our study with available general population 
reference values (Boutouyrie and Vermeersch, 2010). As a result, highly abnormal AS was 
present in 63% of the HIGH-SCI group and 45% of the LOW-SCI group. There was no 
abnormal AS in the age-matched control group. Of note, the clinical threshold for abnormal AS 
values have not been established in the SCI population. These results demonstrate that 
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individuals with high-level SCI may have higher related cardiovascular-related risk compared to 
individuals with low-level SCI.  
Orthostatic Blood Pressure and Renin Levels 
 Our first aim was to investigate the influence of the change in BP and change in plasma 
renin from supine rest to 60-degree HUT. Plasma renin activity has been reported to be elevated 
in response to HUT in persons with high-level injuries (Mathias et al., 29175; Mathias et al., 
1980) in order for this population to regulate BP during an orthostatic provocation. All renin 
values were within normal range (supine: 3-30pg/ml; seated/standing: 7-50 pg/ml) (Bauman et 
al., 2017), except for two individuals in the LOW-SCI group. Both of them had higher supine 
plasma renin levels (Subject 1: 40.31 pg/ml and Subject 2: 78.78 pg/ml) and subject 2 had higher 
than normal plasma renin level during 60-degree HUT (62.76 pg/ml). This may be due to an 
analysis error.  
 The change in plasma renin levels were inversely related to the change in BP from supine 
to HUT at 60-degrees in the total sample. We hypothesized that we would see a positive 
relationship; however, this inverse relationship suggests that those with greatest plasma renin 
response to HUT, also have the greatest fall in BP.  We might have seen an increase in SBP if we 
measured the blood pressure the last 5 minutes of the HUT, instead of the first 5 minutes in order 
to see the increased renin levels vasoconstricting the arteries and increasing BP. Handrakis and 
his colleagues (2009) demonstrated that there was a correlation between change in plasma renin 
and an increase in MAP in individuals with tetraplegia, which suggests that those who have 
increased RAAS activity, had an increase in BP.  
Plasma Renin and Arterial Stiffness 
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Our second aim was to determine if increased reliance on the RAAS for orthostatic BP 
regulation contributes to differences in AS. Overstimulation of RAAS triggers numerous 
signaling pathways that are implicated in vascular remodeling, endothelial dysfunction, and other 
mechanisms that may contribute to AS and accelerated vascular aging (Neves et al., 2018). The 
RAAS system acts predominately on restricting arterioles and, has been shown to modify the 
structure and function by altering collagen and elastin fibers (Mahmud and Freely, 2004; Duprez, 
2006; Neves et al., 2018). Although many studies have hypothesized that increases in RAAS 
may be related to increases in AS in the SCI population (Katzelnick et al., 2017; West et al., 
2013; Wecht and Bauman, 2018), this report is the first to document the change in plasma renin 
during HUT is directly associated with AS in the HIGH-SCI group. The chronic contraction of 
blood vessels and other vascular remodeling processes of RAAS during orthostatic challenges is 
a significant contributor to increased AS.  
Individuals with asymptomatic hypotension are often undiagnosed and untreated because 
it is believed that hypotension may actually have cardiovascular benefit. However, evidence has 
shown adverse impact of asymptomatic OH on activities of daily living (Currie et al., 2015; 
Barber et al., 2000), quality of life (Carlozzi et al., 2013; Craig et al., 2016; Jegede et al., 2010), 
cognitive function (Jegede et al., 2010; Phillips et a l., 2014) and cerebral circulation (Wech et 
al., 2013; Wecht et al., 2012; Phillips et al., 2017) in persons with chronic SCI, and this should 
raise clinical concern. Our findings lend further support that it is necessary to normalize and 
stabilize BP, even in asymptomatic individuals with SCI, to reduce the dependency on RAAS 
and improve cardiovascular health and longevity.  
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Chapter V 
 
 
     SUMMARY AND CONCLUSIONS 
 
 
Conclusion 
The SCI population has an increased prevalence of OH due to impairment in supraspinal 
regulation affecting the autonomic cardiovascular control. Adverse impact of asymptomatic OH 
during activities of daily living, such as transfers and rehabilitation, has not been fully 
appreciated, but should raise clinical concern. Our findings lend further support that the SCI 
population is prone to premature onset of CVD compared to age-matched uninjured able-bodies. 
A new risk factor contributing to increased AS in the SCI population may be the hyperactivity of 
RAAS in order to maintain BP and avoid syncope. Further research should examine 
pharmalogical and nonpharmalogical techniques to increase BP and suppress activation of 
RAAS in order to decrease CVD in the SCI population.  
Limitations 
We acknowledge that the small sample size may limit the generalizability of our findings; 
however, critical factors that affect AS were controlled for in our study, such as age, height, 
weight, and smoking status. Additionally, the sample included a large age range, and we know 
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that AS increases with natural aging. Although we matched our SCI population to the uninjured 
controls, future studies should have a smaller age range to make sure age is not contributing to 
AS. Lastly, we did not survey the SCI sample for autonomic dysreflexia, which is a condition 
that increases BP to possibly extreme levels. Autonomic dysreflexia may play a role in AS since 
AS is affected by BP.  
Future Research 
Future research should examine pharmacological (i.e., hypertensive medication) and 
nonpharmacological (i.e., transcutaneous stimulation) techniques to increase blood pressure and 
suppress activation of RAAS in order to decrease cardiovascular disease in the SCI population.  
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